42.20

0.57% -0.24

After Hours: 42.20

Kiniksa Pharmaceuticals International Plc (KNSA)

Overview News Price History Option Chain Financials Discussions Forecast

Kiniksa Pharmaceuticals International Plc stock is traded at $42.20, with a volume of 597.56K. It is down -0.57% in the last 24 hours and down -0.75% over the past month. Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

Previous Close:

$42.44

Open:

$42.39

24h Volume:

597.56K

Relative Volume:

1.23

Market Cap:

$3.20B

Revenue:

$384.10M

Net Income/Loss:

$-9.07M

P/E Ratio:

-301.43

EPS:

-0.14

Net Cash Flow:

$11.10M

1W Performance:

+7.08%

1M Performance:

-0.75%

6M Performance:

+55.60%

1Y Performance:

+113.45%

1-Day Range:

$41.65

$43.00

1-Week Range:

$38.40

$43.00

52-Week Range:

$18.12

$44.42

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Company Profile

Name

Kiniksa Pharmaceuticals International Plc

Sector

Healthcare (1112)

Industry

Drug Manufacturers - Specialty & Generic (85)

Phone

(781) 431-9100

Address

23 OLD BOND STREET, FLOOR 3, LONDON

Employee

315

Twitter

@kiniksa

Next Earnings Date

2024-10-29

Latest SEC Filings

KNSA's Discussions on Twitter

Compare KNSA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KNSA Kiniksa Pharmaceuticals International Plc	42.20	3.22B	384.10M	-9.07M	11.10M	-0.14
ZTS Zoetis Inc	124.05	54.82B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	16.29	50.36B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	10.46	46.00B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	31.81	36.32B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	468.94	20.33B	3.08B	1.24B	1.07B	25.61

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-29-25	Initiated	TD Cowen	Buy
Mar-13-25	Initiated	Citigroup	Buy
Sep-13-24	Initiated	Jefferies	Buy
May-03-24	Initiated	Wells Fargo	Overweight
Jun-29-20	Reiterated	BofA Securities	Buy
Apr-01-20	Initiated	BofA/Merrill	Buy
Mar-11-19	Initiated	Barclays	Overweight
Dec-12-18	Reiterated	Wedbush	Outperform
Jun-19-18	Initiated	JMP Securities	Mkt Outperform

View All

Kiniksa Pharmaceuticals International Plc Stock (KNSA) Latest News

12:40 PM

Kiniksa: Arcalyst Is The Engine, But KPL-387 Is The Accelerator - Seeking Alpha

12:40 PM

Jan 23, 2026

Kiniksa Pharmaceuticals International, Plc's (NASDAQ:KNSA) Revenues Are Not Doing Enough For Some Investors - 富途资讯

Jan 23, 2026

Jan 18, 2026

Risk Off: Can Kiniksa Pharmaceuticals Ltd reach all time highs this yearQuarterly Profit Summary & Consistent Income Trade Ideas - baoquankhu1.vn

Jan 18, 2026

Campbell & CO Investment Adviser LLC Makes New $1.48 Million Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat

Jan 18, 2026

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Jan 18, 2026

Jan 16, 2026

First Week of March 20th Options Trading For Kiniksa Pharmaceuticals International (KNSA) - Nasdaq

Jan 16, 2026

Jan 15, 2026